Kubota Pharmaceutical
Japan - TokyoPharmaceutical
Focus: Kubota Pharmaceutical is a Japan-based ophthalmology-focused biotech company founded in 2022, developing treatments for dry eye disease, age-related macular degeneration, and glaucoma. The company is early-stage with a pipeline of clinical-phase programs and currently operates at pre-revenue scale.
Profile data last refreshed 2d ago · AI intelligence enriched 2w ago
Open Jobs
0
About Kubota Pharmaceutical
AI assessmentNot HiringNo open roles listed right now. Follow Kubota Pharmaceutical to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
0/9 — Limited
Company HealthSolid
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
ACU-4429
HealthyOPA-6566
Primary Open-angle GlaucomaHelp build intelligence for Kubota Pharmaceutical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.